NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
120 hedge funds and large institutions have $951M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $849M → $951M (+$102M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
120
Holding in Top 10
6
Calls
$8M
Puts
$2.63M
Top Buyers
| 1 | +$33.1M | |
| 2 | +$27.5M | |
| 3 | +$12.2M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.31M |
| 5 |
Two Sigma Investments
New York
|
+$4.09M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$13.9M | |
| 3 | -$6.04M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.83M |
| 5 |
HF
HRT Financial
New York
|
-$1.92M |